6?,7?,15?,16?-Dimethylene-3-oxo-4-androstene-[17(?-1’)-spiro-5’]perhydrofuran-2’-one-d4; 3-Oxo-6?,7?:15?,16?-dimethylene-17?-pregn-4-en-21,17-carbolactone-d4; 1,2-Dihydrospirorenone-d4; Dihydrospirorenone-d4; Drospirenona-d4; YAZ; ZK 30595;Drospirenone-20,20,21,21-d4
Drospirenone-20,20,21,21-d4 is a fully characterized chemical compound used as a reference standard of API Drospirenone. The standard offered is compliant with regulatory guidelines. Drospirenone-20,20,21,21-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 67392-87-4
Related products
6ß,7ß,15ß,16ß-Dimethylene-3ß,5ß-dihydroxyandostan-17-one
M.F.
M.W. 330.47
CAT# AR-D02487
CAS# 82543-16-6
3β,5β-Dihydroxy-15β,16β-methylene-androst-6-en-17-one
M.F.
M.W. 316.44
CAT# AR-D02491
CAS# 82543-15-5
